Legend Biotech Corp. reported a robust performance for Q4 2024, driven by a significant increase in CARVICTI sales. The company achieved net sales of $334 million for CARVICTI, marking a 110% ...

Legend Power Systems reported its financial results for the third quarter of 2025, showing a significant drop in revenue and gross margin compared to the previous year. Revenue was $385,000, down from ...

Earnings call Legend Power Systems reported Q1 revenue of $82,000, up from $2,000 YoY, with gross margin improving to 15% from negative levels. Despite cash constraints, the company executed ...

Legend Biotech Corp (LEGN) reported its third-quarter earnings for 2025, revealing a mixed performance that fell short of market expectations. The company posted an earnings per share (EPS) of -$0.05, ...

Legend Biotech Corp (LEGN) reported its second-quarter earnings for 2025, revealing a significant increase in revenue but a larger-than-expected loss per share. The company’s revenue reached 255.06 ...

Read LEGEND POWER SYSTEMS INC. (LPS.V) Q2 FY2025 earnings call transcript on Yahoo Finance to keep your investing strategy up to date with all of the latest information ...

This is a partial transcript from "Your World with Neil Cavuto," October 24, 2005, that was edited for clarity. NEIL CAVUTO, HOST: Fed head Alan Greenspan (search) — don't let the door hit you in the ...

Can you talk about how your role as manager of NFL player engagement at the league office came to fruition? "It was a fun journey, long process. It was one that for me was tough, because I tore my ACL ...

Good day, and welcome to Legend Biotech Reports Fourth Quarter Earnings Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and ...

We asked (Jonathan) Vilma this yesterday, but where do you think the 2020 Saints prior to taking the field on paper rank among some of best teams the Saints have had over the years? "On paper? I think ...

MS. TUMULTY: Hello, and welcome to Washington Post Live. I’m Karen Tumulty, a columnist and associate editor here at The Post, and it’s my great honor today to welcome my colleague, Max Boot, to talk ...